Trial Profile
Effect of Atazanavir on Endothelial Function in HIV-Infected Patients Compared to Standard Proteinase Inhibitors on Top of Potent Antiviral Combination Therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Antiretrovirals; HIV protease inhibitors
- Indications HIV infections
- Focus Adverse reactions
- Acronyms ENDOPACT
- 06 Jun 2009 New trial record